Home › NDC Lookup › Ingredients › Anastrozole › 65841-0743-10
Anastrozole 1 mg Tablet, Coated, 1,000-count — NDC 65841-0743-10 package photo

Anastrozole 1 mg Tablet, Coated, 1,000-count

by Zydus Lifesciences Limited · 1000 TABLET, COATED in 1 BOTTLE (65841-743-10)
NDC 65841-0743-10
🏷️ FDA NDC (as labeled) 65841-743-10 billing pads the product segment with a zero
This package
Contains1,000-count Pack sizes2 compare ↓
Also priced by: Part D plans $0.3837/unit — full pricing hub ↓
Also comes in: 30 tablets 65841-0743-06
Rx only Generic On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 65841-743-10
Product NDC 65841-743
11-digit billing NDC 65841074310
RxCUI 199224
UNII 2Z07MYW1AZ
Application # ANDA078921
SPL Set ID 965c4cb1-f6b8-47ac-bf13-c36639aa908f
Established class (EPC) Aromatase Inhibitor
Mechanism of action Aromatase Inhibitors
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2010-06-27
Route ORAL
Dosage form TABLET, COATED
Substance ANASTROZOLE
TE code (Orange Book) AB · RLD · RS
Why two NDCs? The FDA registers this code as 65841-743-10 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 65841-0743-10. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Aromatase Inhibitor class.

Pharmacologic class Aromatase Inhibitor
Drug family (ATC) Aromatase inhibitors
How it works Aromatase Inhibitors
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerZydus Lifesciences Limited
Application holderZYDUS PHARMACEUTICALS USA INC
FDA applicationANDA078921 (ANDA)
Labeler code65841
First marketedJun 2010
Product typeHuman Prescription Drug
Portfolio717 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📖 What it is MedlinePlus · NLM

Anastrozole is used with other treatments, such as surgery or radiation, to treat early breast cancer in women who have experienced menopause (change of life; end of monthly menstrual periods). This medication is also used in women, who have experienced menopause, as a first treatment of breast cancer that has spread within the breast or to other areas of the body. This medication is also used to treat breast cancer in women whose breast cancer has worsened after taking tamoxifen (Nolvadex). Anastrozole is in a class of medications called nonsteroidal aromatase inhibitors. It works by decreasi...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Great question. After menopause, your body still makes small amounts of estrogen through an enzyme called aromatase — and many breast cancers use that estrogen as fuel to grow. Ana...
  • What exactly is anastrozole doing in my body to fight breast cancer?
  • You can take it either way — with or without food. Food does slow down how quickly your body absorbs it, but the total amount that gets into your system stays the same. Pick whatev...
  • Can I take anastrozole with food, or does it have to be on an empty stomach?
📖 Read our full Anastrozole guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color White
ShapeRound
ImprintA7
Size6 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII FZ989GH94E
    Povidone is a synthetic polymer made from a plastic-like material. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in your stomach so the medicine can be absorbed.
  • UNII 5856J3G2A2
    A starch-based powder made from potatoes and processed with sodium. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the medicine can be absorbed.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

7 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.3837 $383.70 / 1000 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Anastrozole 1 mg 69117-0003-01 Yiling 30 tablets $0.108 AB FDA listed —
Anastrozole 1 mg 00093-7536-56 Teva 30 tablets $0.140 AB Availability likely —
Anastrozole 1 mg 16729-0035-10 Accord 30 tablets $0.140 AB Availability likely —
Anastrozole 1 mg 23155-0857-03 Avet 30 tablets $0.140 AB Availability likely —
Anastrozole 1 mg 50268-0075-15 AvPAK 50 tablets $0.140 AB Availability likely —
Anastrozole 1 mg 51991-0620-10 Breckenridge 1000 tablets $0.140 AB Availability likely —
Anastrozole 1 mg 59651-0236-30 Aurobindo 30 tablets $0.140 AB Availability likely —
Anastrozole 1 mg 60687-0112-21 American 1 tablet $0.140 AB Availability likely —
Anastrozole 1 mg 62135-0490-30 Chartwell 30 tablets $0.140 AB Availability likely —
Anastrozole 1 mg 68001-0155-04 BluePoint 30 tablets $0.140 AB Availability likely —
Anastrozole 1 mg 68382-0209-06 Zydus 30 tablets $0.140 AB Availability likely —
Arimidex 1 mg 62559-0670-30 ANI 30 tablets $52.862 AB Availability likely —
Anastrozole 1 mg 24979-0725-06 Upsher-Smith 30 tablets — AB FDA listed —
Anastrozole 1 mg 42291-0016-30 AvKARE 30 tablets — AB FDA listed —
Anastrozole 1 mg 42291-0085-30 AvKARE 30 tablets — AB FDA listed —
Anastrozole 1 mg 43063-0383-06 PD-Rx 6 tablets — AB FDA listed —
Anastrozole 1 mg 50090-2453-00 A-S 30 tablets — AB FDA listed —
Anastrozole 1 mg 50090-5002-00 A-S 30 tablets — AB FDA listed —
Anastrozole 1 mg 63187-0080-18 Proficient 18 tablets — AB FDA listed —
Anastrozole 1 mg 63629-5269-00 Bryant 28 tablets — AB FDA listed —
Anastrozole 1 mg 63850-0010-01 Natco 30 tablets — AB FDA listed —
Anastrozole 1 mgthis 65841-0743-10 Zydus 1000 tablets — AB FDA listed —
Anastrozole 1 mg 68071-1543-09 NuCare 90 tablets — AB FDA listed —
Anastrozole 1 mg 68071-1682-03 NuCare 30 tablets — AB FDA listed —
Anastrozole 1 mg 68071-2791-05 NuCare 15 tablets — AB FDA listed —
Anastrozole 1 mg 68071-3838-09 NuCare 90 tablets — AB FDA listed —
Anastrozole 1 mg 68071-3853-07 NuCare 12 tablets — AB FDA listed —
Anastrozole 1 mg 68071-3999-03 NuCare 30 tablets — AB FDA listed —
Anastrozole 1 mg 68071-4038-03 NuCare 30 tablets — AB FDA listed —
Anastrozole 1 mg 68071-5203-03 NuCare 30 tablets — AB FDA listed —
Anastrozole 1 mg 71335-1879-00 Bryant 28 tablets — AB FDA listed —
Anastrozole 1 mg 71335-3145-00 Bryant 28 tablets — AB FDA listed —
Anastrozole 1 mg 72189-0415-30 Direct_Rx 30 tablets — AB FDA listed —
Anastrozole 1 mg 72789-0008-15 PD-Rx 15 tablets — AB FDA listed —
Anastrozole 1 mg 72789-0342-15 PD-Rx 15 tablets — AB FDA listed —
Anastrozole 1 mg 72789-0575-15 PD-Rx 15 tablets — AB FDA listed —
Anastrozole 1 mg 76420-0004-12 Asclemed 120 tablets — AB FDA listed —
Anastrozole 1 mg 82804-0162-30 Proficient 30 tablets — AB FDA listed —
Anastrozole 1 mg 87063-0224-05 ASCLEMED 500 tablets — AB FDA listed —
Anastrozole 1 mg 72189-0682-30 Direct_Rx 30 tablets — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2010
On the market since
Jun 2010
📍
2026
Currently FDA-listed
16 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Anastrozole — the program that covers self-administered drugs. 9 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Anastrozole. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$8.82M
Claims incl. refills
434.6K
Beneficiaries
334.3K
Spend / beneficiary
$26.38
Spend / claim
$20.30
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
65841-0743-06 30 TABLET, COATED in 1 BOTTLE (65841-743-06) 2010-06-27 Active
65841-0743-10 You're viewing this 1000 TABLET, COATED in 1 BOTTLE (65841-743-10) 2010-06-27 Active

You're viewing the largest of 2 pack sizes for this product.

Pack size FAQ

What quantity is in NDC 65841-0743-10?
NDC 65841-0743-10 is a 1,000-count package — 1000 tablet, coated in 1 bottle.
What is the difference between NDC 65841-0743-10 and NDC 65841-0743-06?
Both are Anastrozole 1 mg Tablet, Coated — the drug itself is identical. NDC 65841-0743-10 is the 1,000-count package, while NDC 65841-0743-06 is the 30 tablets package.
What NDC number is used to bill for this package of Anastrozole 1 mg Tablet, Coated?
Bill NDC 65841-0743-10 — the 11-digit billing format is 65841074310. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 65841-743-10, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 65841-0743-10, written without dashes as 65841074310. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 65841-0743-10, the first segment (65841) is the labeler code FDA assigned to Zydus Lifesciences Limited; the middle segment (0743) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (10) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 30 tablets (65841-0743-06). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 9 words ▾

No readable label sections were found for this product.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 65841-0731-01 · Zydus 65841-0751-06 · Zydus →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.